Neuropace shares owned by Bridgeway Capital Management
Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Bridgeway Capital Management
from 13F filings
Historical chart of Bridgeway Capital Management investment in Neuropace
Tip: Access up to 7 years of quarterly data
All positions including Neuropace held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neuropace by Bridgeway Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $340k | 30k | 11.19 |
| 2024-09-30 | $231k | 33k | 6.97 |
| 2024-06-30 | $251k | 33k | 7.56 |
| 2024-03-31 | $438k | 33k | 13.20 |
| 2023-09-30 | $584k | 60k | 9.73 |
| 2023-06-30 | $270k | 60k | 4.49 |
| 2023-03-31 | $240k | 52k | 4.64 |
| 2022-12-31 | $47k | 32k | 1.49 |
| 2022-09-30 | $119k | 32k | 3.76 |
| 2022-06-30 | $129k | 26k | 4.93 |
More positions owned by Bridgeway Capital Management
View all positions for Bridgeway Capital Management